Genomic Health's Q1 Revenues Increase 45 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Genomic Health reported after the close of the market on Tuesday that its first-quarter revenues increased 45 percent, while it trimmed its net loss 30 percent.

The Redwood City, Calif.-based molecular diagnostics firm reported total revenues of $33.9 million compared to revenues of $23.4 million in the first quarter of 2008. All of the Q1 revenue, except for $469,000, came from sales of the firm's Oncotype DX breast cancer test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.